Record #59059
Analysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia Shows High Patient Heterogeneity and the Need for More Consideration of Individualized Treatment
Publisher
Original paper date
Oct 3, 2022
Original DOI
Country
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
0
Same day
1
Post-retraction
0
% post-retraction
0.0%
~0.0 citations/yr before retraction · ~0.0 citations/yr after
— citing papers
Who is still citing this work
Loading…